Table 1.
Baseline diagnosis according to the study group
| Study Group | P‐value* | ||
|---|---|---|---|
| Proflavine Exposed (n = 232, %) | Control (n = 160, %) | ||
| Cytology | |||
| Normal/low‐grade | 54 (23.3) | 36 (22.5) | 0.90 |
| High‐grade | 178 (76.7) | 124 (77.5) | |
| Histopathology | |||
| <CIN2 | 125 (53.9) | 77 (48.1) | 0.30 |
| CIN2+ | 107 (46.1) | 83 (51.9) | |
Normal/low grade = NILM, ASC‐US, LSIL; High grade = ASC‐H, AGC, HSIL, Carcinoma, Adenocarcinoma; < CIN2 = Cervicitis, Hyperplasia, Metaplasia, CIN1, CIN2+ = CIN 2, CIN 3, Adenocarcinoma In‐situ, Carcinoma, Adenocarcinoma. *P‐values calculated using Fisher's exact test.